Lorne Edwards, chief sales officer for Visit Phoenix, checks in with Danielle LeBreck about the rapid growth in Phoenix, especially in the technology sector. Learn how this expansion brings big potential for meetings and conventions.
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
BOSTON, April 08, 2024 Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, today.
Biotech Stock News Bite - Candel Therapeutics, Inc. (Nasdaq: CADL) Big Gains on News of Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409
Candel Therapeutics, Inc. (CADL), a clinical stage biopharmaceutical company, announced Thursday positive interim survival data from the ongoing randomized phase 2 clinical trial of CAN-2409 in Non-Metastatic Pancreatic Cancer.